ognizant Communication Corporation

GENE EXPRESSION

AUTHOR AND SUBJECT INDEXES: VOLUMES 8 & 9

VOLUME 9, 1999

Author Index

Abasolo, I., 183
Allaman-Pillet, N., 93
Amendt, B. A., 265
Anderson, L. M., 157
Angerer, L. M., 283
Angerer, R. C., 283
Annunziato, A. T., 37

Bailleul-Winslett, P. A., 145
Banerjee, A. K., 115
Bonny, C., 93
Bradfield, C. A., 291
Brown, T. R. P., 15
Brueggemeier, R. W., 157

Cai, X., 183
Cao, W.-Q., 173, 291
Casto, B. C., 157
Chen, Y., 103, 133
Cheng, L., 257
Cherkaoui-Malki, M., 291
Chernoff, Y. O., 145
Choudhary, S., 115
Concannon, C. G., 195
Cook, W. S., 173
Costa, R. H., 217, 237

Dadras, S. S., 173, 183
Datta, S., 249
De, B. P., 115
DeGroff, V., 157
Dervan, P. B., 77
Djemaï, A., 93

Egly, J.-M., 3
El-Osta, A., 63
 

 Gao, J., 115
Ghoshal, K., 203
Goldman, E., 257
Gottsfeld, J. M., 77
Green, P. D., 265
Gronostajski, R. M., 203

Hansen, J. C., 37
Hjalt, T. A., 265
Hughes, D. E., 217

Jacob, S. T., 203

Kenny, A. P., 283
Kirk, D. E., 265
Knobloch, T. J., 157
Kovesdi, I., 237

Latruffe, N., 291
Lynch, M. A., 157

Major, M. L., 217
Majumder, S., 203
Manley, J. L., 123
Meyer, K., 291
Murray, J. C., 265

Newnam, G. P., 145
Nyborg, J. K., 29

Orrenius, S., 195

Perumal, K., 133
Pesold, C., 217
Petrel, T. A., 157
 

 Ramljak, D., 157
Rao, M. S., 173. 291
Reddy, J. K., 173, 291
Reddy, R., 133
Reichel, R. R., 237
Riedl, T., 3
Russo, A. F., 265

Samali, A., 195
Schorderet, D. F., 93
Scott, P. H., 15
Sharpe, P. T., 265
Snead, M. L., 265
Song, H., 157
Stein, T., 15
Stoner, G. D., 157
Sutherland, L. B., 265

Tan, Y., 237
Thomas, B. L., 265
Turner, J. M., 77

Um, M., 123

Van Orden, K., 29

Wang, Z., 173, 183
Weghorst, C. M., 157
Wegrzyn, R. D., 145
White, R. J., 15
Williams, B. R. G., 103
Winter, A. G., 15
Wolffe, A. P., 63

Yeldandi, A. V., 173, 291
Yeldandi, A. V., 291
Yoo, K., 217

Zhou, H., 217

Subject Index

Acetylation, 37
Actin, 145
Activation domain, 123
Androgen-response genes, 183
Apoptosis, 195
Assembly, 37
Astrocytes, 217
5-aza 2´deoxycytidine, 63

Breast cancer, 157

Caspase, 195
CCAAT, 283
Cell cycle, 15
Cerebellar expression, 217
Chromatin, 37
Chromatin remodeling, 63
Conserved tandem repeats, 93
CREB binding protein (CBP), 29
CTD, 3
Cycloheximide, 145
Cytochrome c, 195

Dihydrotestosterone, 183
Dlx2, 265
DNA bending, 283
DNA methyltransferase, 63
DNA microarray analysis, 291
Drosophila, 123

Endogenous gene expression, 103

Fatty acyl-CoA oxidase, 173
Folding, 37
Fragile X syndrome, 63
Frog oocytes, 133

Gene expression data, 249
Gene transcription, 77
Granule cells, 217
Growth inhibition, 157
GTFs, 3

 Hepatocyte nuclear factor 3, 237
Histone, 37
Histone deacetylase, 63
HMG, 283
Hsp27, 195
Human parainfluenza virus type 3 (HPIV3), 115

Inflammation, 115
Intercellular adhesion molecule-1 (ICAM-1), 115

Liver, 291
Ly-6D, 173

Mammalian cells, 133
Metal transcription factor-1 (MTF-1), 203
Metallothionein, 203
Methyl-CpG binding proteins, 63
Methylphosphate cap structure, 133
Microarray, 249
Modeling, 249
Molecular medicine, 77

Neuronal migration, 217
NF-kB, 103
NF-kB super repressor, 103
Novel therapies, 77
N-terminal domain, 123
Nuclear factor I (NFI), 203
Nucleosome, 37

p16INK4, 63
p53, 15
Partial least squares, 249
Peroxisome proliferator(s), 173, 291
Peroxisome proliferator-activated receptor-a (PPARa), 173, 291
Phosphorylation, 3
PITX2, 265
pol III, 15
Protein aggregation, 145
[PSI], 145
Purkinje cells, 217

 RB, 15
5a-Reductase, 183
Reeler mice, 217
Release factor, 145
Retinoic acid stimulation, 237
Rett syndrome, 63
RNA polymerase pause sites, 257
RNA translation, 133

Sodium azide, 145
Sonic hedgehog, 237
Steric hindrance of transcription starts, 257
Stress, 195
Structure, 37
Sup35p, 145

T7 expression systems, 257
T7 transcription terminator, 257
Tails, 37
TATA binding protein, 123
Tax oncoprotein, 29
Testosterone, 183
TFIIIB, 15
Therapeutic strategies, 77
Transcription, 15
Transcription activators, 3
Transcription regulation, 3
Transcriptional activity, 93
Transcriptional regulation, 265
Transformation, 15
Transforming growth factor-\GK\b, 157
Transforming growth factor-\GK\b receptors, 157
Transgenic mice, 217
Transthyretin, 237
Transthyretin promoter, 217
Tumor suppression, 29

Wilms tumor suppressor gene, 103
Winged helix domain, 217
WT1, 103

X inactivation, 93
Xist gene, 93

Yeast, 249

VOLUME 8, 1999

Author Index

Ait-Si-Ali, S., 33
Almasan, A., 197
Andrew, S. D., 311
Attal, J., 299

Bache, A., 151
Barbulescu, K., 115
Barchi, R. L., 85
Becker, C., 115
Beckerle, M. C., 207
Benecke, B.-J., 105, 165
Breindl, M., 151
Brenner, D. A., 151
Brockmann, D., 1
Byrom, M. W., 219

Cao, W.-Q., 231
Capes-Davis, A., 311
Casto, B. C., 129, 327, 341
Chen, C.-L., 219
Christensen, T. H., 247
Cook, W., 231
Cooper, K. F., 43

Depping, R., 187
Dixit, M. N., 219
Dorsman, J. C., 19
Dwight, T., 311

Elliott, W. M., 287
Enomoto, T., 341
Esche, H., 1

Fang, J., 129, 327
Forney, J. D., 263

Gagandeep, S., 175
Gillan, A., 151
Gilmore, T. D., 207
Goldman, E., 141
Gong, B., 197
Groisman, R., 33
Grotkopp, D., 151
Gupta, S., 175

 

 Hall, K., 151
Harel-Bellan, A., 33
Harvey, B., 141
Hayashi, S., 287
Higashimoto, Y., 287
Hogg, J. C., 287
Houdebine, L. M., 299
Hyland, V. J., 311

Jain, S., 231

Kallen, R. G., 85
Kan, L., 231
Kanwar, Y. S., 231
Kedes, L., 247
Keicho, N., 287
Kerr, L. D., 219
Kohtz, D. S., 59
Kohtz, J. D., 59
Korus, M., 141
Krempen, K., 151
Kukushkin, A. N., 19
Kumar, M. B., 273

Learoyd, D. L., 311
Li, B., 175
Li, D., 129, 327
Lieb, M. A., 59
Lipinski, K. S., 1

Ma, Q., 175
Magnaghi-Jaulin, L., 33
Maldonado, M. N., 85
Marsh, D. J., 311
Masutani, H., 33
McClaid, M. R., 341
Medvedev, A. V., 19
Menzies, K., 59
Meyer zum Büschenfelde, K.-H., 115
Michels, D., 165
Milo, G. E., 129, 327
Moschella, M. C., 59
Murata, Y., 341
Murphy, K., 207

Nakashima, R., 341
Neurath, M. F., 115
Noyes, I., 129, 327

Ossenbühl, F., 165
Ott, M., 175

 Perdew, G. H., 273
Pettersson, S., 115
Pospelov, V. A., 19
Pospelova, T. V., 19
Pritchard, L. L., 33
Puissant, C., 299
Pützer, B. M., 1

Rao, M. S., 231
Reddy, J. K., 231
Rippe, R. A., 151
Robin, P., 33
Robinson, B. G., 311
Rödicker, F., 165
Roebuck, K. A., 67
Rogler, L. E., 175
Rüger, W., 187

Saifuddin, M., 67
Sandrock, B., 105
Schmücker, U., 1
Shuler, C., 129
Sohur, U. S., 219
Song, H., 341
Strich, R., 43
Sun, X. L., 129, 327
Svetlikova, S. B., 19

Taubman, M. B., 59
Thai, K. Y., 263
Theil, K., 129
Theron, M.-C., 299
Tiemann, B., 187
Tsao, L., 59
Twigg, S., 311

Usuda, N., 231

Van Der Eb, A. J., 19

Wang, Y., 207
Weghorst, C. M., 341
Wirtz, S., 115

Yeldandi, A. V., 231
Yi, J., 207

Zhang, H., 85
Zhao, M. K., 207

Subject Index

a-Amanitin sensitivity, 165
a1(I) collagen, 151
Activator protein-1, 67
Adenovirus E1A, 287
ADP-ribosyltransferase, 187
AFT-2/c-jun, 115
Alt, 187
Alternative splicing, 311
Antibody staining, 59
Antisense cDNA, 129
AP-1/ATF, 1
AP-1 transcription factors, 19
Ary hydrocarbon receptor (AhR), 273

B cell development, 219
bax, 197
BCL-2, 219
Bicistronic mRNA, 299

cDNA transfection, 327
Cell cycle, 197
Cell-free extract, 165
c-fos, 33
Chromatin, 67
Chromosome 13, 129
cis-Element, 85
Coactivator, 207, 273
"Cold" SSCP, 341
Concatemer junction, 141
Cyclin C, 43

Dexamethasone, 311
Dioxin, 273
Distal regulatory elements, 151
dUTPase, 231

E1A and cHa-ras oncogenes, 19
E-box, 247
Electrophoresis mobility shift analysis, 85
Embryonic development, 231
Endometrial carcinoma, 341
Enhancer, 151
Ets, 33
Expression, 85
External promoter, 105

fos and jun expression, 19
 

 gadd45, 197
Gene expression, 175, 311
GPI-anchored protein, 263
Green fluorescent protein, 151

Hepatitis B virus, 175
HIV-1, 67

ICAM-1 promoter, 287
In vivo footprinting, 115
Inflammatory stimuli, 287
Internal elements, 105
Internal ribosome entry site (IRES), 299
Ionizing radiation, 197

7S K promoter, 105
7S L RNA, 165

L6 myotubes, 85
Leucine zipper, 43
LIM domain, 207
Liver, 175
Long terminal repeat, 67
Lung epithelial cells, 287
LXXLL motif, 231
Lysogeny, 187

Malignant conversion, 129
Malignant transformation, 207
Matrix metalloproteinase, 327
MEF-2, 247
MEF-3, 247
Metastasis, 327
MHC class I, 1
ML-1, 129
ModA, 187
ModB, 187
Mouse embryo, 59
Multiple endocrine neoplasia type 2, 311
Muscle, 247
Mutational analysis, 341
Myocyte differentiation, 59
Myogenesis, 59

Nerve growth factor (NGF), 33
Nuclear factor kappa B (NF-kB), 1, 67, 207, 219

Overexpression, 187

 p21/waf1, 197
p300, 1
Paramecium, 263
PC12, 33
Phage T4, 187
Polymerase III, 105
PPAR, 231
Preproparathyroid hormone, 141
Progenitor B cells, 219
Programmed cell death or apoptosis, 219
Promoter, 67, 115
Protein-protein interaction, 43
Protein purification, 187

RET proto-oncogene, 311
Retroviral oncogene, 207
RNA polymerase II holoenzyme, 43
RNA polymerase III transcription, 165
RNase protection, 197

Schizosaccharomyces pombe, 165
Serum response element (SRE), 33
Skeletal muscle, 59, 85
SM-20, 59
Sodium channel, 85
Somites, 59
SP1/Egr, 115
SRC-1, 273
Stem cell, 175

T7 promoter, 141
Tat, 67
TGFb receptors, 341
TNF, 115
Transcription, 219, 247, 263
Transcription factor(s), 67, 175, 207
Transcription regulation, 187
Transgenic mice, 151
Translation, 299
Translation regulation, 187
Trip6, 207
Troponin C gene, 247
Two-hybrid assay, 207

Uterus, 151

Variable surface antigen, 263
v-Rel, 207